|
Overview |
Product information | Accredo services |
Contact team
Aldurazyme is the first enzyme replacement therapy to specifically treat the underlying cause of MPS I. The main ingredient in Aldurazyme is a highly purified protein identical to a naturally occurring form of the human enzyme alpha-L-iduronidase.
Aldurazyme replaces the missing enzyme alpha-L-iduronidase, treating the underlying cause of MPS I. By providing the body with a source of alpha-L-iduronidase, Aldurazyme restores sufficient enzyme activity to break down GAG buildup.
Aldurazyme has been shown to help people with MPS I by improving lung function, functional capacity, and endurance (e.g., walking ability) and by reducing the size of the enlarged liver.
For more information, please visit Aldurazyme.com, or download the full prescribing information.
Aldurazyme is a registered trademark of Genzyme Corporation.
| 
